Webinars

  1. Sustainable Approaches To Oligonucleotide Manufacturing

    An industry expert shares about sustainable Oligo manufacturing approaches that can save time, cost, and resources – while improving purity, quality, and scalability of these promising therapeutics.

  2. Single-Use Technology For Quality mRNA Manufacturing

    Learn how single-use technologies deliver important benefits for mRNA manufacturing, including increased speed, quality, flexibility, and adaptability to different dosages and scale-up strategies.

  3. Nanoparticle Enabled Formulation And Drug Delivery Solutions

    Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

  4. Quantifying Cell Response With Duplex RT-qPCR

    Discover a new potency bioassay using RT-qPCR to assess relative transcription activity, and learn more about the advantages and limitations of transcriptional assays versus reporter gene assays.

  5. All Eyes On mRNA: Addressing Key Insights Into The Next Blockbuster

    With ongoing development efforts seeing infinite possibilities for cancers, autoimmune diseases, and genetic diseases, how should the industry apply this early victory into successful mRNA-based therapeutics and vaccines?

  6. Engaging Early In Process Development To Bring mRNA Sequences To Life

    Examine why template sequence characteristics are relevant for cGMP manufacturing of high-quality mRNA and consider insights on how to develop a scalable, robust, and economically viable process.

  7. Smart Bioprocess Data Utilization For Advanced Analytics And Monitoring With Data Analytics Tools Purpose-Built For Bioprocessing

    We share our experience working with organizations as they adopt solutions for automated data acquisition, aggregation, visualizations, and statistical analysis.

  8. Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

    Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

  9. Addressing Industry Challenges In mRNA Product Commercialization

    While the speed of production and flexibility of mRNA are appealing, several industry challenges must still be addressed to realize the full potential and further expand its use.

  10. Knowledge Transfer, Training Collaboration For Suppliers & Manufacturers

    Watch to learn how a SUT supplier and a biomanufacturer can successfully work together to create an effective training program for GMP-compliant, aseptic, single-use bioprocesses.